Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery

Abstract The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Davide Lazzeroni, Luca Moderato, P. L. Marazzi, Carmen Pellegrino, Elisa Musiari, Paolo Castiglioni, Umberto Camaiora, Matteo Bini, Simone Geroldi, Lorenzo Brambilla, Valerio Brambilla, Paolo Coruzzi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fc0d8ee42629402f88079585943dcf98
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fc0d8ee42629402f88079585943dcf98
record_format dspace
spelling oai:doaj.org-article:fc0d8ee42629402f88079585943dcf982021-12-02T14:27:53ZRed blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery10.1038/s41598-021-87075-42045-2322https://doaj.org/article/fc0d8ee42629402f88079585943dcf982021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87075-4https://doaj.org/toc/2045-2322Abstract The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan–Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan–Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19–1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23–1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01–1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01–1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation.Davide LazzeroniLuca ModeratoP. L. MarazziCarmen PellegrinoElisa MusiariPaolo CastiglioniUmberto CamaioraMatteo BiniSimone GeroldiLorenzo BrambillaValerio BrambillaPaolo CoruzziNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Davide Lazzeroni
Luca Moderato
P. L. Marazzi
Carmen Pellegrino
Elisa Musiari
Paolo Castiglioni
Umberto Camaiora
Matteo Bini
Simone Geroldi
Lorenzo Brambilla
Valerio Brambilla
Paolo Coruzzi
Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
description Abstract The red blood cell distribution width (RDW) measures the variability in the size of circulating erythrocytes. Previous studies suggested a powerful correlation between RDW obtained from a standard complete blood count and cardiovascular diseases in both primary and secondary cardiovascular prevention. The current study aimed to evaluate the prognostic role of RDW in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. The study included 1.031 patients with available RDW levels, prospectively followed for a mean of 4.5 ± 3.5 years. The mean age was 68 ± 12 years, the mean RDW was 14.7 ± 1.8%; 492 patients (48%) underwent cardiac rehabilitation after myocardial revascularization, 371 (36%) after cardiac valve surgery, 102 (10%) after valve-plus-coronary artery by-pass graft surgery, 66 (6%) for other indications. Kaplan–Meier analysis and Cox hazard analysis were used to associate RDW with mortality. Kaplan–Meier analysis demonstrated worse survival curves free from overall (log-rank p < 0.0001) and cardiovascular (log-rank p < 0.0001) mortality in the highest RDW tertile. Cox analysis showed RDW levels correlated significantly with the probability of overall (HR 1.26; 95% CI 1.19–1.32; p < 0.001) and cardiovascular (HR 1.31; 95% CI 1.23–1.40; p < 0.001) mortality. After multiple adjustments for cardiovascular risk factors, hemoglobin, hematocrit, C-reactive protein, microalbuminuria, atrial fibrillation, glomerular filtration rate,left ventricular ejection fraction and number of exercise training sessions attended, the increased risk of overall (HR 1.10; 95% CI 1.01–1.27; p = 0.039) and cardiovascular (HR 1.13; 95% CI 1.01–1.34; p = 0.036)mortality with increasing RDW values remained significant. The RDW represents an independent predictor of overall and cardiovascular mortality in secondary cardiovascular prevention patients undergoing cardiac rehabilitation.
format article
author Davide Lazzeroni
Luca Moderato
P. L. Marazzi
Carmen Pellegrino
Elisa Musiari
Paolo Castiglioni
Umberto Camaiora
Matteo Bini
Simone Geroldi
Lorenzo Brambilla
Valerio Brambilla
Paolo Coruzzi
author_facet Davide Lazzeroni
Luca Moderato
P. L. Marazzi
Carmen Pellegrino
Elisa Musiari
Paolo Castiglioni
Umberto Camaiora
Matteo Bini
Simone Geroldi
Lorenzo Brambilla
Valerio Brambilla
Paolo Coruzzi
author_sort Davide Lazzeroni
title Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_short Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_full Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_fullStr Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_full_unstemmed Red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
title_sort red blood cell distribution width as a novel prognostic marker after myocardial revascularization or cardiac valve surgery
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fc0d8ee42629402f88079585943dcf98
work_keys_str_mv AT davidelazzeroni redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT lucamoderato redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT plmarazzi redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT carmenpellegrino redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT elisamusiari redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT paolocastiglioni redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT umbertocamaiora redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT matteobini redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT simonegeroldi redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT lorenzobrambilla redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT valeriobrambilla redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
AT paolocoruzzi redbloodcelldistributionwidthasanovelprognosticmarkeraftermyocardialrevascularizationorcardiacvalvesurgery
_version_ 1718391288690114560